Frontier Medicines
Presence
Acquisition, funding and merger involving Frontier Medicines.
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Frontier Medicines
- Chris Varma, Chairman and Chief Executive Officer
- Cameron Wheeler, Director
- Sisi Pouraghabagher, Director
Popular executive movements at Frontier Medicines
- Gregory Chow, Chief Financial Officer, has left the company (posted on February 6 2024).
Create your alert
to follow the executive moves at Frontier Medicines.
Pharmaceuticals
Frontier Medicines has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Frontier Medicines
- Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting | Frontier Medicine
- Frontier Medicines to Present Preclinical Data at the American Association of Cancer Research Annual Meeting 2024 | Frontier Medicine
- Frontier gets $80M, Galapagos’ backing to make a better KRAS drug
- Frontier Medicines to Participate in Upcoming Investor Conferences | Frontier Medicine
- Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline | Frontier Medicine
- Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial - San Francisco Business Times
- Frontier Medicines to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Frontier Medicine
- Frontier Medicines’ press releases
- Frontier Medicines Announces Appointment of Andrew Krivoshik, M.D., Ph.D., as Chief Medical Officer | Frontier Medicine
- Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting | Frontier Medicine
- View more press releases Close
Social media about Frontier Medicines
- Frontier Medicines on Wikipedia, Google News & Yahoo Finance
- Frontier Medicines on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Chris Varma 
Call Frontier Medicines at +1 650...
